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Mitochondrial disorders are a wide spectrum and heterogeneous disorders that 
are first described in the early 1960s. It can be said that mitochondrial disorders 
are the most common Neurometabolic diseases of childhood. Thesedisordersnot 
only present with nonspecific symptoms, but also there is not a reliable biomarker 
specific for the screening of them. However increased plasma level of lactate or 
pyruvate can be considered an important marker of mitochondrial disease. As a 
general rule, the involvement of 3 or more organ symptoms without a unifying 
diagnosis should raise suspicion of mitochondrial disease. 
Mitochondria are the main source of energy for all human tissues and contain 
many metabolic pathways, including the pyruvate dehydrogenase complex 
[PDHC], the carnitine cycle, the β-oxidation system, and the Krebs cycle. 
Defects in any of these pathways cause mitochondrial disorders. The reducing 
agents produced in the Krebs cycle and in the β-oxidation systems are transferred 
along the electron transport chain that in turn consists of four multimeric 
enzyme complexes (I to IV) plus two small electron carriers, coenzyme Q and 
cytochrome c. The energy produced by these reactions is used to pump protons 
from the mitochondrial matrix into the space between the inner and outer 
mitochondrial membranes.This “proton pumping” generates an electrochemical 
proton gradient, which is utilized by the last enzyme complex (complex V or 
ATP synthase) to produce ATP in a process known as oxidation/phosphorylation 
coupling. Electron transport chain and oxidative phosphorylation together are 
called “respiratory chain”, or oxidative phosphorylation (OXPHOS) system. 
This system is controlled by both nuclear and mitochondrial DNA (nDNA and 
mDNA) and is the only metabolic pathway under dual control of both nuclear 
and mitochondrial genomes. Indeed,complexes I, III, IV, and V contain some 
subunits encoded by mtDNA and all subunits of complex II, most subunits of 
the other four complexes, as well as CoQ10 and cytochrome c are encode by 
nDNA.
The term “primary mitochondrial disease” or “mitochondrial encephalomyopathy” 
refers specifically to mitochondrial dysfunction caused by genetic mutations, 
directly impacting the composition and function of the electron transport 
chain. Other Metabolic disorders that are associated with lactic acidosis are 
include: amino acid disorders, organic acidemias, urea cycle defects, pyruvate 
metabolism defects, Krebs cycle defects, mitochondrial OXPHOS disorders, 
disorders of liver glycogen metabolism, disorders of liver gluconeogenesis and 
biotidinase deficiency. Therefore, when mitochondrial dysfunction is confirmed 
by sophisticated biochemical testing, it can be challenging to distinguish whether 
the cause for this dysfunction is a gene that directly impacts the electron-
transport chain or is secondary to an unrelated genetic or environmental cause.
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Table 1: Genetic Classification of Mitochondrial Disorders Based on MDNA and NDNA Abnormalities.




I)Mutations in genes 




Kearns-sayre syndrome CoQ10 deficiency
Sporadic PEO


















The third group of disorders that are related to NDNA defect are including: Freidreich’s ataxia, Hereditary spastic 
paraplegia (HSP) and X-linked ataxia and sideroblastic anemia.
patient, the genetic basis of mitochondrial disorders is 
more likely to be caused by mDNA rather than nDNA 
abnormalities, so we can conclude that Common primary 
mitochondrial diseases in older patients are included 
disorders that are caused by mDNA-deletion and point 
mutations (e.g., Kearns- Sayre syndrome, MELAS and 
Leber hereditary optic neuropathy).
A-Disorder related to MDNA defects: this group can 
be divided in two main subgroups: Disorders that are 
caused by deletions and duplications in mitochondrial 
DNA, and II) Disorders that are caused point mutations 
in mitochondrial DNA.
B-Disorders related to NDNA defects: Inheritance 
pattern of these disorders are Mendelian and are 
included: I) Mutations in genes encoding proteins of the 
respiratory chain, II) Defects of intergenomic signaling, 
and III) Mutations of genes indirectly involved in 
OXPHOS.
Nowadays Primary mitochondrial disorders are 
genetically divided in two main categories: mitochondrial 
DNA disorders (mDNA) and nuclear DNA disorders 
(nDNA). Nuclear genes Mutations are being considered 
the main reason of pediatric mitochondrial disease. This 
finding is explained by the predominance of proteins 
expressed in the mitochondria that are synthesized by 
nDNA (about 850 genes) compared with mDNA (13 
genes).Therefore, it can be said that Autosomal recessive 
inheritance of nuclear genes disorders is likely the most 
common cause of mitochondrial disorders in children. 
Primary abnormalities of mDNA are: point mutations, 
deletions, and duplications. Inheritance pattern of Point 
mutations are maternal, but Deletions and duplications 
in mDNA are commonly inherited by sporadic pattern. 
mDNA abnormalities cause different disorders based on 
clinical view and therefore are heterogeneous, but some 
disorders such as Leigh disease and or MELAS are seen 
commonly. Interestingly, with increasing the age of the 
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Introduction of the modified Gomoritri chrome 
stain, revealed “ragged-red fibers” (RRF) in muscle 
biopsy of patients that suffer from mitochondrial 
and consideredthe pathological hallmark of human 
mitochondrialmyopathy.Based on this pathologic finding 
Mitochondrial syndromes can be divided in two large 
groups: I) those with positive RRF in muscle biopsy, 
I) those with negative RRF in muscle biopsy. The first 
group, are included following disorders: MERRF, PEO, 
MELAS and Pearson syndrome and the latter group are 
consisting of Leigh encephalopathy, NARP, MDS and 
LHON.
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